QIAGEN
at the problem space and take a different approach than you would have in the past. What was a standard security solution five years ago may not be the most appropriate solution nowadays as the threat landscape has progressed and so should our thinking on how to protect our most important assets. “We have brought in consulting partners to speed up and assist with optimising our investment in security technologies. Complete assessment of our M365 security stack, then understand what our customers expect – both features but increasingly also security prioritised implementation of the most impactful security improvements. “QIAGEN has a long-standing relationship with TCS who give us access to many highly skilled experts across various areas who are able to quickly scale up as needs arise. TCS is a trusted partner of ours and easy to work with due to our long relationship,” said Schatz . Impact of the pandemic on cybersecurity Commenting on how the pandemic has impacted the work at QIAGEN with their “Sample to Insight” solutions, Schatz said: “The pandemic showed us the relevance of molecular testing in the research and healthcare value chains. QIAGEN played a crucial role in the first testing protocols. “But the pandemic had a noticeable impact on QIAGEN in many ways. On one hand, demand for our COVID 19-related products and services increased sharply. On the other hand, we were impacted by shortages of crucial materials to keep up with demand and a high percentage of our employees had to work remotely. “Global demand outpaced what the entire industry could provide. As a critical supplier during the pandemic, our employees worked 250
September 2021
“Attacks are increasing, which is little surprise considering how quickly organised cybercriminals are improving their craft” DR DANIEL SCHATZ
CHIEF INFORMATION SECURITY OFFICER, QIAGEN
around the clock to develop new solutions and ramp up manufacturing of key products. We collaborated with our suppliers, logistics partners, and customers to strengthen our supply chain. QIAGEN has utilised the additional revenues from our COVID19 testing kits and automation platforms to develop solutions that will be relevant beyond the pandemic. “However, the traditional workplace dissolved so instead of having one office